| 000 | 01882 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250516132851.0 | ||
| 264 | 0 | _c20140116 | |
| 008 | 201401s 0 0 eng d | ||
| 022 | _a1527-3350 | ||
| 024 | 7 |
_a10.1002/hep.26277 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGordon, Stuart C | |
| 245 | 0 | 0 |
_aEfficacy of tenofovir disoproxil fumarate at 240 weeks in patients with chronic hepatitis B with high baseline viral load. _h[electronic resource] |
| 260 |
_bHepatology (Baltimore, Md.) _cAug 2013 |
||
| 300 |
_a505-13 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenine _xanalogs & derivatives |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aDNA, Viral _xblood |
| 650 | 0 | 4 |
_aDeoxycytidine _xanalogs & derivatives |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aEmtricitabine |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHepatitis B virus _xgenetics |
| 650 | 0 | 4 |
_aHepatitis B, Chronic _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLongitudinal Studies |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOrganophosphonates _xtherapeutic use |
| 650 | 0 | 4 |
_aPhosphorous Acids _xtherapeutic use |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aViral Load |
| 700 | 1 | _aKrastev, Zahary | |
| 700 | 1 | _aHorban, Andrzej | |
| 700 | 1 | _aPetersen, Jörg | |
| 700 | 1 | _aSperl, Jan | |
| 700 | 1 | _aDinh, Phillip | |
| 700 | 1 | _aMartins, Eduardo B | |
| 700 | 1 | _aYee, Leland J | |
| 700 | 1 | _aFlaherty, John F | |
| 700 | 1 | _aKitrinos, Kathryn M | |
| 700 | 1 | _aRustgi, Vinod K | |
| 700 | 1 | _aMarcellin, Patrick | |
| 773 | 0 |
_tHepatology (Baltimore, Md.) _gvol. 58 _gno. 2 _gp. 505-13 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/hep.26277 _zAvailable from publisher's website |
| 999 |
_c22461952 _d22461952 |
||